Outlook Therapeutics
OTLK
OTLK
52 hedge funds and large institutions have $10.8M invested in Outlook Therapeutics in 2025 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
4% less funds holding
Funds holding: 54 → 52 (-2)
67% less call options, than puts
Call options by funds: $1.26M | Put options by funds: $3.89M
Holders
52
Holding in Top 10
–
Calls
$1.26M
Puts
$3.89M
Top Buyers
| 1 | +$2.76M | |
| 2 | +$477K | |
| 3 | +$258K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$196K |
| 5 |
State Street
Boston,
Massachusetts
|
+$140K |
Top Sellers
| 1 | -$144K | |
| 2 | -$63K | |
| 3 | -$48.1K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$37.8K |
| 5 |
SA
Sanctuary Advisors
Indianapolis,
Indiana
|
-$35.5K |
